Developing strategic alliances and partnerships is an integral part of Sphaera’s corporate strategy. Sphaera is committed to partnering with leading academics, biotechnology and pharmaceutical companies with a shared passion for developing innovative therapies for patients with unmet medical needs.
Sphaera is an entrepreneurial organization that allows for a variety of business models and deal structures that promote both partnership and productivity:
• Collaborative drug discovery research
• Capital efficient value added R&D capabilities
• Risk shared co-development
• In- and out-license drug candidates at various stages
• Equity/ Spin-outs
We are always looking for opportunities to combine experience and resources with other organizations where specific projects may benefit. Our most promising partner is the one who recognizes the value of having a strong, complementary, collaborative scientific team capable of achieving joint research and development goals. For all partnering inquiries, please contact our business development team at